Table 2 Multivariate Cox proportional hazard models for the LBA and Dako, Leica and Ventana ready-to-use immunohistochemical assays

From: Evaluation of three commercial progesterone receptor assays in a single tamoxifen-treated breast cancer cohort

 

HR

95% Confidence interval

P-value

Ligand binding

0.75

(0.39–1.43)

0.377

Dako

0.65

(0.31–1.37)

0.261

Leica

0.83

(0.33–2.09)

0.693

Ventana

0.5

(0.22–1.12)

0.090

  1. Abbreviation: LBA, ligand-binding assay.
  2. All models were adjusted for lymph node status, tumor grade, tumor size and HER2 status.